Table 2.
Top 20 most commonly prescribed QTc-prolonging medications in the study cohort from 3- months prior to diagnosis up to and including date of diagnosis
| QT-prolonging medication | Medication category | TdP risk Classification | Rate of Usage *(%) |
|---|---|---|---|
| Azithromycin | Antimicrobial | Known | 4.5 |
| Citalopram | Psychiatric | Known | 4.3 |
| Moxifloxacin | Antimicrobial | Known | 3.4 |
| Vardenafil | Erectile dysfunction | Possible | 2.7 |
| Ciprofloxacin | Antimicrobial | Known | 2.6 |
| Levofloxacin | Antimicrobial | Known | 2.4 |
| Mirtazapine | Psychiatric | Possible | 2.3 |
| Ondansetron | Antiemetic | Known | 2.1 |
| Gatifloxacin | Antimicrobial | Known | 1.4 |
| Venlafaxine | Psychiatric | Possible | 1.3 |
| Promethazine | Antiemetic | Possible | 1.3 |
| Donepezil | Psychiatric | Known | 1.1 |
| Amiodarone | Cardiovascular | Known | 1 |
| Risperidone | Psychiatric | Possible | 0.9 |
| Methadone | Analgesic | Known | 0.7 |
| Cilostazol | Cardiovascular | Known | 0.7 |
| Nortriptyline | Psychiatric | Possible | 0.6 |
| Fluconazole | Antimicrobial | Known | 0.5 |
| Clarithromycin | Antimicrobial | Known | 0.4 |
| Chloroquine | Antirheumatict† | Known | 0.4 |
3 months prior to or at Cohort Entry Date
Less commonly prescribed as an anYmicrobial for prevenYon or treatment of malaria